MED29 抗体 (AA 29-184) (FITC)
Our Local Distributor
北京 101111
Quick Overview for MED29 抗体 (AA 29-184) (FITC) (ABIN8008643)
抗原
See all MED29 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 29-184
-
原理
- Anti-MED29 Antibody FITC Conjugated
-
交叉反应 （详细）
- No cross-reactivity with other proteins.
-
纯化方法
- Immunogen affinity purified.
-
免疫原
- E.coli-derived human MED29 recombinant protein (Position: Q29-K184).
-
亚型
- IgG
-
-
anti-Mediator Complex Subunit 29 (MED29) (AA 1-221) antibody
MED29 适用: 人 WB, IF 宿主: 小鼠 Polyclonal unconjugated
anti-Mediator Complex Subunit 29 (MED29) (Internal Region) antibodyMED29 适用: 人, 小鼠, 大鼠 WB, ELISA, IF, ICC, IHC 宿主: 兔 Polyclonal unconjugated
anti-Mediator Complex Subunit 29 (MED29) (AA 98-147) antibodyMED29 适用: 人, 小鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Mediator Complex Subunit 29 (MED29) (Center) antibodyMED29 适用: 人, 小鼠, 大鼠, Cow, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Mediator Complex Subunit 29 (MED29) (Middle Region) antibodyMED29 适用: 人, 小鼠, 大鼠, Cow, 犬, 马, Pig, 兔, 斑马鱼 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
有效期
- 12 months
-
-
- MED29 (Mediator Complex Subunit 29 (MED29))
-
别名
- MED29
-
背景
-
Background: Mediator of RNA polymerase II transcription subunit 29 (Med29) is a transcription suppressor that in humans is encoded by the MED29 gene. MED29 is a subunit of the Mediator complex, a multiprotein coactivator of RNA transcription that interacts with DNA-bound transcriptional activators, RNA polymerase II and general initiation factors.
Gene Full Name: mediator complex subunit 29
-
基因ID
- 55588
-
UniProt
- Q9NX70
-
途径
- Regulation of Lipid Metabolism by PPARalpha
抗原
-
